Deferasirox

Overview

Deferasirox is an iron chelator used to reduce chronic iron overload in patients who receive long-term blood transfusions. It binds to iron and allows its elimination from the body, thereby preventing damage to organs from excess iron deposition.

API suppliers (25)

Suppliers of Deferasirox evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• TAPI NL BVNetherlands2 active DMF
• AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)India1 active DMF
• Zhejiang Hengkang Pharmaceutical Co., Ltd.China1 active DMF GMP on record
• SMS Pharmaceuticals limitedIndia1 active DMF GMP on record
• CTX LIFESCIENCES PVT LTD1 active DMF
• Neuland Laboratories LimitedIndia1 active DMF
• JUBILANT BIOSYS LTDIndia1 active DMF
• PURE AND CURE HEALTHCARE PRIVATE LTDIndia1 active DMF
• MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
• ALIVUS LIFE SCIENCES LTDIndia1 active DMF GMP on record
• Alembic Pharmaceuticals LimitedIndia1 active DMF GMP on record
• Biocon LimitedIndia1 active DMF
• WATERSTONE PHARMACEUTICALS (HUBEI) CO LTDChina1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
• MEDILUX LABORATORIES PVT LTDIndia1 active DMF GMP on record
• Cipla USA, Inc.USA1 active DMF
• Piramal Pharma LimitedIndia1 active DMF GMP on record
• YUNG ZIP CHEMICAL IND CO LTD1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• Viyash Scientific LtdIndia1 active DMF GMP on record
• Apotex Pharmachem India Pvt. Ltd.India
• BACHEM INCSwitzerland GMP on record
• ERREGIERRE SPAItaly GMP on record
• MSN Laboratories Private LimitedIndiaCEP GMP on record
• CTX LIFE SCIENCES PVT LTDIndia

Patent & exclusivity (US)

Per the FDA Orange Book (84 approved US products), the latest listed US patent on Deferasirox expires 21 Nov 2034. Generic API sourcing typically opens up once these lapse.

Therapeutic areas